NEWS FEED & ADDITIVE MAGAZINE January 2024 69 Nutreco announced that Eduardo Lopes Alberto has been appointed VP of Innovation and Research for Trouw Nutrition starting in January 2024. Before joining Nutreco, Alberto spent seven years at dsm-firmenich as Vice President of North America and most recently as their Vice President of Global Innovation, Animal Nutrition, and Health, where he focused on driving strategic investments and successful launches of innovative technologies and services worldwide. Before joining dsm, Eduardo Lopes Alberto spent 16 years at Elanco Animal Health, with diverse global roles in marketing, sales, and R&D and managing business operations in the USA, Asia, and Latin America. Alberto is a Doctor of Veterinary Medicine, holds an MBA from the University of São Paulo, Brazil, and is a specialised postgraduate in marketing from Escola Superior de Propaganda e Marketing (ESPM), Brazil. He also completed the General Management Programme at Harvard Business School. In this role, Alberto will be responsible for Global Innovation at Trouw Nutrition, with primary responsibility for ensuring the development and delivery of the global innovation agenda and stewarding the innovation investment. Eduardo will report to David Blakemore, CEO of Trouw Nutrition. “I’m delighted that Eduardo is joining the team and bringing his two-decades of commercial and industry experience and innovation leadership to Trouw Nutrition and Nutreco,” said David Blakemore. Read more>> Eduardo Lopes Alberto joins Trouw Nutrition team as VP Innovation and Research Eduardo Lopes Alberto Mootral, a British biotech company, announced that it completed the in vitro development and testing phase and is now commencing a range of in vivo trials of its Enterix Advanced technology, set to significantly boost the methane reduction efficacy of the original Enterix™ product while maintaining productivity benefits essential for wide-scale farmer adoption. Enterix Advanced incorporates a patented technology that harnesses the power of iodoform, known for its methane-inhibiting properties, by synergizing it with specific active compounds from garlic. This approach builds on Mootral's original technology, which is already in use on UK commercial farms. The key lies in the strong synergy between these compounds, allowing for significant emission reductions without impacting dry matter intake or milk yield, a potential problem previously associated with high doses of iodoform. Mootral's new technology allows for the controlled release formulation necessary for bolus administration in grazing cattle, vastly increasing the potential for methane mitigation in animal agriculture globally. "A known methane suppressant, iodoform, has the same mode of action as bromoform, the active ingredient in some species of seaweed proposed for methane reduction," said Thomas Hafner, Founder and CEO of Mootral. Read more>> Mootral introduces new methane reduction technology, Enterix Advanced
RkJQdWJsaXNoZXIy MTUxNjkxNQ==